<VariationArchive RecordType="classified" VariationID="40249" VariationName="NM_007215.4(POLG2):c.1423_1424del (p.Leu475fs)" VariationType="Deletion" Accession="VCV000040249" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2018-09-11" MostRecentSubmission="2018-09-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="48733" VariationID="40249">
      <GeneList>
        <Gene Symbol="POLG2" FullName="DNA polymerase gamma 2, accessory subunit" GeneID="11232" HGNC_ID="HGNC:9180" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="64477785" stop="64497054" display_start="64477785" display_stop="64497054" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="62473901" stop="62493183" display_start="62473901" display_stop="62493183" Strand="-" />
          </Location>
          <OMIM>604983</OMIM>
        </Gene>
        <Gene Symbol="MILR1" FullName="mast cell immunoglobulin like receptor 1" GeneID="284021" HGNC_ID="HGNC:27570" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="64449115" stop="64497356" display_start="64449115" display_stop="64497356" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="62461566" stop="62464759" display_start="62461566" display_stop="62464759" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_007215.4(POLG2):c.1423_1424del (p.Leu475fs)</Name>
      <CanonicalSPDI>NC_000017.11:64477856:AAAAA:AAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="64477857" stop="64477858" display_start="64477857" display_stop="64477858" variantLength="2" positionVCF="64477856" referenceAlleleVCF="CAA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="62473974" stop="62473975" display_start="62473974" display_stop="62473975" variantLength="2" positionVCF="62473973" referenceAlleleVCF="CAA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L475fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.62473977_62473978del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.62473977_62473978del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.64477860_64477861del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.64477860_64477861del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013029.1" sequenceAccession="NG_013029" sequenceVersion="1" change="g.24210_24211del">
            <Expression>NG_013029.1:g.24210_24211del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007215.4" sequenceAccession="NM_007215" sequenceVersion="4" change="c.1423_1424del" MANESelect="true">
            <Expression>NM_007215.4:c.1423_1424del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009146.2" sequenceAccession="NP_009146" sequenceVersion="2" change="p.Leu475fs">
            <Expression>NP_009146.2:p.Leu475fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="604983.0005" DB="OMIM" />
        <XRef Type="rs" ID="1568079613" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_007215.4(POLG2):c.1423_1424del (p.Leu475fs) AND Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4" Accession="RCV000033247" Version="7">
        <ClassifiedConditionList TraitSetID="1464">
          <ClassifiedCondition DB="MedGen" ID="C1864668">Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-09-11" MostRecentSubmission="2018-09-11">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21555342</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1464" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3385" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 4</ElementValue>
                <XRef Type="MIM" ID="610131" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4</ElementValue>
                <XRef ID="MONDO:0012415" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PEOA4</ElementValue>
                <XRef Type="MIM" ID="610131" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29517884</ID>
                <ID Source="BookShelf">NBK487393</ID>
              </Citation>
              <XRef ID="C1864668" DB="MedGen" />
              <XRef ID="MONDO:0012415" DB="MONDO" />
              <XRef Type="MIM" ID="610131" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="95541" SubmissionDate="2018-09-08" DateLastUpdated="2018-09-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604983.0005_PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4" title="POLG2, 2-BP DEL, 1423TT_PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4" />
        <ClinVarAccession Accession="SCV000057103" DateUpdated="2018-09-11" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an 8-year-old boy with progressive external ophthalmoplegia (PEOA4; 610131), Young et al. (2011) identified a heterozygous 2-bp deletion (1423delTT) in the last exon of the POLG2 gene, resulting in a frameshift and premature termination (Leu475AspfsTer2). The location of the mutation in the last exon was predicted to escape nonsense-mediated mRNA decay. In vitro functional expression studies showed that the mutant protein could not bind DNA, had significantly decreased affinity to p140, and was unable to stimulate p140-mediated primer extension. The mutant protein also showed abnormal folding, with aggregation due to the formation of aberrant disulfide bonds. The patient had neonatal hypotonia, developmental delay, seizures, constipation, abnormal liver enzymes, ketosis, cortical blindness, and cerebellar atrophy.</Attribute>
              <Citation>
                <ID Source="PubMed">21555342</ID>
              </Citation>
              <XRef DB="OMIM" ID="610131" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLG2" />
          </GeneList>
          <Name>POLG2, 2-BP DEL, 1423TT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 1423TT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604983.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="95541" TraitType="Disease" MappingType="Name" MappingValue="PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4" MappingRef="Preferred">
        <MedGen CUI="C1864668" Name="Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

